← Back to Discover
FCPM III SERVICES B.V.
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $750,409,524
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- NEWAMSTERDAM PHARMA COMPANY · ORDINARY SHARES · N62509109 · shares: $287,738,063
- MAPLIGHT THERAPEUTICS INC · COM · 56565P103 · shares: $115,634,176
- DYNE THERAPEUTICS INC · COM · 26818M108 · shares: $85,469,766
- VOR BIOPHARMA INC · COM NEW · 929033207 · shares: $75,800,487
- DAMORA THERAPEUTICS INC · COM NEW · 36322Q206 · shares: $63,490,410
- REPLIMUNE GROUP INC · COM · 76029N106 · shares: $31,088,634
- CRESCENT BIOPHARMA INC. · COM · G2545C104 · shares: $30,201,336
- AURA BIOSCIENCES INC · COM · 05153U107 · shares: $28,781,803
- ENGENE HOLDINGS INC · COM · 29286M105 · shares: $16,664,330
- BICYCLE THERAPEUTICS PLC · SPONSORED ADS · 088786108 · shares: $14,706,143
Reported holdings
15 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | — | 4,648,025 shares | $157,521,567 |
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | — | 3,842,328 shares | $130,216,496 |
| MAPLIGHT THERAPEUTICS INC | COM | 56565P103 | — | 3,226,400 shares | $115,634,176 |
| VOR BIOPHARMA INC | COM NEW | 929033207 | — | 4,117,354 shares | $75,800,487 |
| DAMORA THERAPEUTICS INC | COM NEW | 36322Q206 | — | 2,441,000 shares | $63,490,410 |
| DYNE THERAPEUTICS INC | COM | 26818M108 | — | 2,421,886 shares | $53,790,088 |
| DYNE THERAPEUTICS INC | COM | 26818M108 | — | 1,426,370 shares | $31,679,678 |
| REPLIMUNE GROUP INC | COM | 76029N106 | — | 2,808,368 shares | $31,088,634 |
| CRESCENT BIOPHARMA INC. | COM | G2545C104 | — | 1,677,852 shares | $30,201,336 |
| AURA BIOSCIENCES INC | COM | 05153U107 | — | 4,053,775 shares | $28,781,803 |
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | — | 3,468,430 shares | $14,706,143 |
| ENGENE HOLDINGS INC | COM | 29286M105 | — | 6,738,362 shares | $11,657,366 |
| ENGENE HOLDINGS INC | COM | 29286M105 | — | 2,894,199 shares | $5,006,964 |
| ENGENE HOLDINGS INC | W EXP 10/31/2028 | 29286M113 | — | 2,403,072 shares | $696,651 |
| ENGENE HOLDINGS INC | W EXP 10/31/2028 | 29286M113 | — | 475,076 shares | $137,725 |